IPERIONX Ltd director Lorraine M. Martin purchased 4,100 American Depository Shares (ADS) of IPX at $24.51 per ADS in an open-market transaction on July 10, 2026. Following the trade, she holds 8,855 ADS, 1,177,138 ordinary shares and 90,216 RSUs, with 76,054 RSUs vesting in December 2026 and 14,162 in December 2027. Each ADS is equivalent to 10 ordinary shares.
IPERIONX Ltd President Toby Edgcumbe Symonds reported an open-market purchase of 2,040 American Depository Shares (ADS) of IPX at $24.55 per ADS, representing 20,400 Ordinary Shares. Following this trade, he holds 39,040 ADS, equivalent to 390,400 Ordinary Shares, plus 3,128,089 IPX Ordinary Shares directly. He also holds 703,199 RSUs and a substantial package of options and performance rights over additional Ordinary Shares at exercise prices between A$4 and A$22, with expirations between 2028 and 2031.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reported an open-market purchase of 138,720 IPX Ordinary Shares on July 10, 2026 at an average price of A$3.5844 per share, bringing his directly held Ordinary Shares to 12,455,502. He also directly holds 738,576 Restricted Stock Units, multiple option and performance-right awards over Ordinary Shares at exercise prices between A$6 and A$22, and 128,000 American Depository Shares (ADS), each ADS representing ten Ordinary Shares.
IPERIONX Ltd Executive Chairman Todd Hannigan reported open-market purchases of IPX Ordinary Shares. He bought 225,000 shares on July 10, 2026 at an average price of $3.5786 per share and 300,000 shares on July 13, 2026 at $3.5866 per share, for total recent purchases of 525,000 shares. Following these transactions, he directly holds 26,633,334 Ordinary Shares, along with 454,464 RSUs, 500,000 ADS (each ADS convertible into 10 Ordinary Shares), and various options and performance rights over additional Ordinary Shares.
IperionX Limited is conducting an underwritten public offering of 2,275,000 American Depositary Shares at $21.98 per ADS, for aggregate gross proceeds of about $50 million before fees and expenses. Each ADS represents 10 ordinary shares, totaling 22,750,000 ordinary shares.
The offering is led by U.S. institutional investors and is expected to close on July 9, 2026, subject to customary conditions. IperionX plans to use the proceeds to commercialize and scale its titanium and metal alloy production technologies, expand its Titanium Manufacturing Campus in Virginia, advance the Camden-Titan Project in Tennessee, and for general corporate purposes. Cantor Fitzgerald is sole book-running manager, with Roth Capital Partners and B. Riley Securities as co-managers.
IperionX Limited is conducting a firm commitment public offering of 2,275,000 ADSs, each ADS representing ten ordinary shares, at a public offering price of $21.98 per ADS. The offering is being sold by the company and is expected to deliver proceeds to the issuer.
Net proceeds are estimated at approximately $46.0 million after underwriting discounts, commissions and estimated offering expenses. The ADSs are listed on Nasdaq under the symbol IPX. Ordinary shares outstanding immediately after this offering are stated as 359,072,679 ordinary shares.
IperionX Limited proposes a firm commitment public offering of American Depositary Shares (ADSs), each representing 10 ordinary shares, to raise capital to advance commercialization and scale-up of its titanium production technologies and to support the Titan-Camden critical minerals development.
Recent operational and financing context disclosed includes HAMR™ powder production of approximately 4.2 metric tons in March 2026 (about 50 metric tons per year annualized), a US$47.1 million Industrial Base Analysis and Sustainment award supporting a 1,400 metric tons per year expansion program, receipt of approximately 290 metric tons of titanium scrap from the U.S. Government, and US$48.2 million in cash as of March 31, 2026. The prospectus supplement describes use of proceeds for Virginia manufacturing scale-up, Titan-Camden activities and general corporate purposes.
IperionX Limited has completed the strategic acquisition of the Camden critical mineral, property, and infrastructure assets in Tennessee, adjacent to its Titan Critical Minerals Project. Camden brings ultra-high-grade surface stockpiles of total heavy minerals (THM), with bulk samples grading 9.9% and 23.0% THM, significantly above Titan’s 2.2% THM resource grade.
The acquisition secures mineral rights, pre-stripped Lower McNairy mineralized areas across approximately 180 acres, and an existing industrial processing hub with power, water, gas and rail. Camden’s stockpiles and pre-stripped zones may provide a higher-grade, potentially lower-capital-intensity pathway for titanium, zircon and heavy rare earth feedstocks.
IperionX plans drilling and resource-definition work at Camden to quantify the stockpiled and pre-stripped material, aiming to support an integrated Camden-Titan platform for U.S.-sourced titanium, zircon and rare-earth-bearing mineral products used in defense, aerospace, electrification and high-performance magnet technologies.
IperionX Limited has been awarded up to US$6.6 million under a U.S. Department of War program funded by the Office of the Secretary of War Submarine Workforce and Industrial Base (OSW-SWIB) to scale titanium plate and component production at its Titanium Manufacturing Campus in Virginia.
The program runs in two phases, with US$0.2 million for initial scoping and test work and, upon successful completion, a further US$6.4 million for capital equipment and expanded capacity. IperionX will apply its patented HAMR™, HSPT™ and THRM™ powder-to-plate technologies to produce ballistic-grade titanium plate and large-format components for demanding maritime and land defense applications, in collaboration with Texas A&M’s George H.W. Bush Combat Development Complex and the U.S. Army Research Laboratory. The company also received a prototype order for titanium fasteners for the Joint Light Tactical Vehicle, reinforcing its role in the U.S. defense industrial base.
IperionX Limited agreed to acquire key assets from Covia Solutions’ Camden, Tennessee silica sand operation for US$3,000,000 in cash. The facility sits adjacent to IperionX’s Titan Project within the Big Sandy Critical Minerals Province and the McNairy Formation, which is prospective for titanium, zircon and rare earth minerals.
The assets include mining and processing equipment, surface and mineral rights, existing mineral stockpiles, rail-related infrastructure, utilities, buildings, and about 1,400 acres of owned plus roughly 1,400 acres of leased property. IperionX will also assume Covia’s land reclamation obligations.
Titan remains the cornerstone asset, with a JORC Code mineral resource containing about 10 million metric tons of rare earth, titanium and zircon mineral sands across more than 11,000 acres. At full production, Titan is expected to produce around 5,000 tpa of rare earth concentrate, 110,000 tpa of titanium minerals and 36,000 tpa of zircon minerals to support U.S. critical material supply chains.